References
Levy WC: Observational studies of statins in systolic heart failure. Heart Fail Clin 2008, 4:201–208.
Krum H, Latini R, Maggioni AP, et al.: Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT. Int J Cardiol 2007, 229:48–53.
Kjekshus J, Apetrei E, Barrios V, et al., for the CORONA group: Rosuvastatin in older patients with heart failure. N Engl J Med 2007, 357:2248–2261.
Sander S, Coleman CI, Patel AA, et al.: The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 2006, 12:464–472.
Rauchhaus M, Clark A, Doehner W, et al.: The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 2003, 42:1933–1940.
Marxcoff L, Thompson P: The role of coenzyme Q10 in statin associated myopathy: a systematic review. J Am Coll Cardiol 2007, 49:2231–2237.
Marchioli R, Levantesi G, Silletta MG, et al.: Effect of n-3 polyunsaturated fatty acids with rosuvastatin in patients with heart failure: results of the GISSI-HF trial. Exp Rev Cardiovasc Ther 2009, 7:735–748.
Disclosure
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clearfield, M. Rosuvastatin and Clinical Outcomes in Individuals Who are not Deemed Appropriate for Baseline Statin Therapy. Curr Atheroscler Rep 12, 5–7 (2010). https://doi.org/10.1007/s11883-009-0082-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11883-009-0082-y